FDA Ramps Up Data Gathering On How To Regulate Nanotech In Drugs, Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
By 2015, some predict, nanotechnology will play a critical role in up to 60% of biopharma products.
You may also be interested in...
Nanotech Working Group Is Getting Down To The Fine Details Of Defining It
An international scientific working group is trying to describe the defining characteristics of nanotechnology drugs to help support regulatory development in this nascent field
Nanotech Working Group Is Getting Down To The Fine Details Of Defining It
An international scientific working group is trying to describe the defining characteristics of nanotechnology drugs to help support regulatory development in this nascent field
FDA Nano Meeting Just the Beginning Of Supplement, OTC Questions
Sept. 8 open meeting to address need for nano-regulations, no small undertaking.